Showing results (61-70 of 494) with videos related to
Sort By:
Pageof 50
Annals of Surgical Oncology|February 26, 2015
Sentinel Lymph Node Dissection in Head and Neck Melanoma has Prognostic Impact on Disease-Free and Overall SurvivalUlrike Leiter, Thomas K Eigentler, Hans-Martin Häfner, et al.Cancers|December 10, 2021
Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical ChemistryLina María Serna-Higuita, Teresa Amaral, Andrea Forschner, et al.Melanoma Research|March 14, 2008
Management of primary and metastasized melanoma in Germany in the time period 1976-2005: an analysis of the Central Malignant Melanoma Registry of the German Dermatological SocietySilke S Schwager, Ulrike Leiter, Petra G Buettner, et al.Journal of the American Academy of Dermatology|June 25, 2011
Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma RegistryUlrike Leiter, Petra G Buettner, Thomas K Eigentler, et al.Journal of Clinical Medicine|July 19, 2020
A Systematic Review and Meta-Analysis of Interventions for Actinic Keratosis from Post-Marketing Surveillance TrialsTheresa Steeb, Anja Wessely, Matthias Harlaß, et al.The Journal of Investigative Dermatology|July 25, 2017
Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma RegistryMaximilian Gassenmaier, Thomas Kurt Eigentler, Ulrike Keim, et al.Journal of the American Academy of Dermatology|February 1, 2019
Age as key factor for pattern, timing, and extent of distant metastasis in patients with cutaneous melanoma: A study of the German Central Malignant Melanoma RegistryMaximilian Gassenmaier, Ulrike Keim, Ulrike Leiter, et al.Expert Opinion on Biological Therapy|February 23, 2016
Intralesional immunotherapy as a strategy to treat melanomaNoura Nouri, Claus GarbeExpert Opinion on Pharmacotherapy|April 18, 2017
Non-melanoma skin cancer: new and future synthetic drug treatmentsTeresa Amaral, Claus GarbePigment Cell Research|May 20, 2003
Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological dataJürgen Bauer, Claus GarbePageof 50